Clinical Pharmacology of Fast-Acting Insulin Aspart Versus Insulin Aspart Measured as Free or Total Insulin Aspart and the Relation to Anti-Insulin Aspart Antibody Levels in Subjects with Type 1 Diabetes Mellitus

Greater early postprandial suppression of endogenous glucose production and higher initial glucose disappearance is achieved with fast-acting insulin aspart compared with insulin aspart

(2018) Ananda Basu et al.   DIABETES OBESITY & METABOLISM

A Comparison of Pharmacokinetic and Pharmacodynamic Properties Between Faster-Acting Insulin Aspart and Insulin Aspart in Elderly Subjects with Type 1 Diabetes Mellitus

(2016) Tim Heise et al.   DRUGS & AGING

Pharmacokinetic and prandial pharmacodynamic properties of insulin degludec/insulin aspart in children, adolescents, and adults with type 1 diabetes

(2016) Torben Biester et al.   PEDIATRIC DIABETES

Faster-acting insulin aspart: earlier onset of appearance and greater early pharmacokinetic and pharmacodynamic effects than insulin aspart

(2015) T. Heise et al.   DIABETES OBESITY & METABOLISM

Principles and pitfalls of free hormone measurements

(2013) James D. Faix   BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM

Insulin antibodies - are they still with us? Do they matter?

(2011) Georgeanna J. Klingensmith   PEDIATRIC DIABETES